Efficacy of FOLFOX Alone, FOLFOX Plus Bevacizumab and FOLFOX Plus Panitumumab in Patients With Resectable Liver Metastases

Clinical trial NCT01508000 · TERMINATED

Trial details

NCT number

NCT01508000

Sponsor

European Organisation for Research and Treatment of Cancer - EORTC

Status

TERMINATED

Phase

Phase 2

Study type

INTERVENTIONAL

Start date

2013-06-01

Primary completion

2016-09-01

Enrollment

44

View on ClinicalTrials.gov